SLP (Simulations Plus) 3-1 Month Momentum %: 27.00% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SLP Simulations Plus Inc SLP
86 GF Score
Price $18.23
GF Value $35.40
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus 3-1 Month Momentum %?

Simulations Plus SLP -0.05% 86 3-1 Month Momentum % is 27.00% as of Jul. 18, 2026. GuruFocus rates SLP with a GF Score™ of 86/100 and a GF Value™ of $35.40 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 676 Healthcare Providers & Services companies, Simulations Plus ranks better than 92.75% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-18), Simulations Plus's 3-1 Month Momentum % is 27.00%.

The industry rank for Simulations Plus's 3-1 Month Momentum % or its related term are showing as below:

SLP's 3-1 Month Momentum % is ranked better than
92.75% of 676 companies
in the Healthcare Providers & Services industry
Industry Median: -3.985 vs SLP: 27.00

Simulations Plus  (NAS:SLP) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Simulations Plus 3-1 Month Momentum % Related Terms


SLP vs TBRG, CARL, NRC: 3-1 Month Momentum % Comparison

For the Health Information Services subindustry, Simulations Plus's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus 3-1 Month Momentum % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Simulations Plus's 3-1 Month Momentum % falls into.


SLP
86GF Score
Simulations Plus Inc SLP
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus  (NAS:SLP) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 27.00% mean?
Simulations Plus (SLP) has a 3-1 Month Momentum % of 27.00% as of Jul. 18, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Simulations Plus and its competitors. According to the industry distribution chart, Simulations Plus ranks #49 out of 676 companies in the Healthcare Providers & Services industry, placing it in the top 7.2%.
Is Simulations Plus' 3-1 Month Momentum % too high?
Simulations Plus' current 3-1 Month Momentum % is 27.00%. Based on the distribution chart, Simulations Plus ranks #49 out of 676 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Simulations Plus has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' 3-1 Month Momentum % compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #49 out of 676 companies for 3-1 Month Momentum %. This places Simulations Plus in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Simulations Plus and its competitors. Simulations Plus's current 3-1 Month Momentum % is 27.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $35.40, compared to a current price of $18.23 — trading 48.5% below its estimated fair value. The current 3-1 Month Momentum % is 27.00%. Simulations Plus' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Simulations Plus (SLP), the current 3-1 Month Momentum % is 27.00% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (SLP) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of $18.23 is trading 48.5% below its estimated GF Value™ of $35.40. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for SLP:

  • 3-1 Month Momentum %: 27.00%
  • GF Value™: $35.40 vs. price of $18.23 (48.5% below fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Simulations Plus Business Description

Other Exchanges SD3:Germany
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
86GF Score

Get the complete analysis for SLP

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.23
Price
$35.40
GF Value